Treatment Response Assessment of Head and Neck Cancers on CT Using Computerized Volume Analysis

References

1. 1..↵
   Cancer Facts & Figures 2009. American Cancer Society; 2009. http://www.cancer.org/downloads/STT/500809web.pdf. Accessed December 2, 2009
2. 2.↵
   1. Pignon JP,
   2. Bourhis J,
   3. Domenge C,
   4. et al

   . Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000; 355: 949– 55

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Bourhis J,
   2. Le Maitre A,
   3. Baujat B,
   4. et al

   . Individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol 2007; 19: 188– 94

   CrossRefPubMed
4. 4.↵
   1. Jeremic B,
   2. Shibamoto Y,
   3. Milicic B,
   4. et al

   . Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000; 18: 1458– 64

   Abstract/FREE Full Text
5. 5.↵
   1. Adelstein DJ,
   2. Li Y,
   3. Adams GL,
   4. et al

   . Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92– 98

   Abstract/FREE Full Text
6. 6.↵
   1. Urba SG,
   2. Moon J,
   3. Giri PG,
   4. et al

   . Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group trial. J Clin Oncol 2005; 23: 88– 95

   Abstract/FREE Full Text
7. 7.↵
   Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: the Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685– 90

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Lefebvre JL,
   2. Chevalier D,
   3. Luboinski B,
   4. et al

   . Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial—EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88: 890– 99

   Abstract/FREE Full Text
9. 9.↵
   1. Forastiere AA,
   2. Goepfert H,
   3. Maor M,
   4. et al

   . Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091– 98

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Mancuso AA,
    2. Mukherji SK,
    3. Schmalfuss I,
    4. et al

    . Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999; 17: 631– 37

    Abstract/FREE Full Text
11. 11.↵
    1. Hermans R,
    2. Van den Bogaert W,
    3. Rijnders A,
    4. et al

    . Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys 1999; 44: 755– 65

    CrossRefPubMed
12. 12.↵
    1. Chua DT,
    2. Sham JS,
    3. Kwong DL,
    4. et al

    . Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997; 39: 711– 19

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Johnson CR,
    2. Thames HD,
    3. Huang DT,
    4. et al

    . The tumor volume and clonogen number relationship: tumor-control predictions based upon tumor volume estimates derived from computed-tomography. Int J Radiat Oncol Biol Phys 1995; 33: 281– 87

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Freeman DE,
    2. Mancuso AA,
    3. Parsons JT,
    4. et al

    . Irradiation alone for supraglottic larynx-carcinoma: can CT findings predict treatment results? Int J Radiat Oncol Biol Phys 1990; 19: 485– 90

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Pameijer FA,
    2. Mancuso AA,
    3. Mendenhall WM,
    4. et al

    . Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int J Radiat Oncol Biol Phys 1997; 37: 1011– 21

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Mukherji SK,
    2. Toledano AY,
    3. Beldon C,
    4. et al

    . Interobserver reliability of computed tomography-derived primary tumor volume measurement in patients with supraglottic carcinoma. Cancer 2005; 103: 2616– 22

    CrossRefPubMed
17. 17.↵
    World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: WHO Publications Centre; 1979: Publication No. 48
18. 18.↵
    1. Therasse P,
    2. Arbuck SG,
    3. Eisenhauer EA,
    4. et al

    . New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205– 16

    Abstract/FREE Full Text
19. 19.↵
    1. Husband JE,
    2. Schwartz LH,
    3. Spencer J,
    4. et al

    . Evaluation of the response to treatment of solid tumours: a consensus statement of the International Cancer Imaging Society. Br J Cancer 2004; 90: 2256– 60

    PubMedWeb of Science
20. 20.↵
    1. Hadjiiski L,
    2. Mukherji SK,
    3. Ibrahim M,
    4. et al

    . Head and neck cancers on CT: preliminary study of treatment response assessment based on computerized volume analysis. AJR Am J Roentgenol. 2010; 194: 1083– 89

    CrossRefPubMed
21. 21.↵
    1. Street E,
    2. Hadjiiski L,
    3. Sahiner B,
    4. et al

    . Automated volume analysis of head and neck lesions on CT scans using 3D level set segmentation. Med Phys 2007; 34: 4399– 408

    CrossRefPubMed
22. 22.↵
    1. Shrout P,
    2. Fleiss J.

    . Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86: 4202– 08
23. 23.↵
    1. Bland J,
    2. Altman DG

    . Statistical methods for assessing agreement between 2 methods of clinical measurement. Lancet 1986; 1: 307– 10

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Altman DG,
    2. Bland J

    . Measurement in medicine: the analysis of method comparison studies. Statistician 1983; 32: 307– 17

    CrossRefWeb of Science